Therapure Biopharma Inc of Mississauga is one of the only Canadian companies to do large-scale protein purification, so their services are in high demand. That demand, according to company President and CEO Tomas Wellner, has led to a $27.9 million retrofitting and expansion of Therapure's
Mississauga bio-manufacturing facility that will create 100 new jobs at the company.
"We're adding jobs that are high-value," Wellner said, noting that the company's work is subject to the "highest end of regulatory controls" and that new hires are and will be made up of the cream of the PhD crop and well-trained skilled operators.
Wellner says the expansion will take about 18 months to complete, after which production will be ramped up to serve expected global demand for the protein-based bioproducts the company manufactures. Such products are used to treat illnesses such as infectious diseases, cancer and anemia.
Part of the project will be financed through a
$4.2 million grant from the Ontario Ministry of Research and Innovation. The remaining money will be a private investment by the company's owners.
Author: Edward Keenan
Source: Thomas Wellner, President and CEO, Therapure Biopharma Inc.
Got an Innovation & Job News tip? Email [email protected].